Director of the Center for Lasers and Aesthetics - Brown Dermatology, Inc.
Medical Director of Clinical Trials at the Department of Dermatology of the Warren Alpert Medical School of Brown University.
Dermatology scholar with lectures in the most important national and international dermatology meetings. Expert in procedural aesthetic dermatology. Internationally recognized for research and training on chemabrasion modalities (chemical peeling), particularly phenol-croton oil peels. Expert in Lipolysis. Dr Wambier has coined the term #Emptiers.
Also researches infectious and autoimmune diseases, and environmental factors to skin diseases, safety in dermatologic procedures and drug reactions, applied phytochemistry, wound healing, neocollagenesis, scars, and severe drug-induced skin reactions. Dermatologist at the Rhode Island Hospital Burn Center.
Since 2020, became an active researcher of COVID-19 vulnerability mechanisms, including the androgen TMPRSS2 gateway to SARS-CoV-2 cell infection, antiandrogen therapy, and environmental and seasonal vulnerability.
Has ministered +50 Hands-on Workshops on Advanced Chemical Peels, +20 Hands-on Workshops on Emptiers and Drug Tattooing.
Chemical Peels CME articles and before-after photographs featured as cover of the 40th aniversary of the Journal of the American Academy of Dermatology, August 2019
Cover of “The Dermatologist”, November 2018.
Chair of Cosmetic Dermatology sessions in the World Congress of Dermatology, Italy (2019) and World Congress of Cosmetic Dermatology, Peru (2019), American Academy of Dermatology Global Day (2023).
Inventions / Innovations / Intelectual Property:
USPTO patent #11,253,465. “Compositions and methods for treating skin conditions.” February 22, 2022.
USPTO Patent #11,576,812. “Methods for reducing body fat”. February 14, 2023.
Twitter: @WambierMD
Nguyen C, Yale K, Ghigi A, Zheng K, Mesinkovska NA, Wambier CG, Cadegiani FA, Goren A. "SARS-CoV-2 infection in patients with thyroid disease: a cross-sectional study." Annals of thyroid, vol. 6, 2022. |
McCoy J, Cadegiani FA, Wambier CG, Herrera S, Vaño-Galván S, Mesinkovska NA, Ramos PM, Shapiro J, Sinclair R, Tosti A, Goren A. "5-alpha-reductase inhibitors are associated with reduced frequency of COVID-19 symptoms in males with androgenetic alopecia." Journal of the European Academy of Dermatology and Venereology, vol. 35, no. 4, 2021, pp. e243-e246. |
MacDonald S, Matos de Oliveira A, Wambier CG. "Androgen Deprivation Therapy in Men with Prostate Cancer Does Not Affect Risk of Infection With SARS-CoV-2. Letter." The Journal of Urology, vol. 206, no. 3, 2021, pp. 784-785. |
Goren A, Cadegiani FA, Wambier CG, Vano-Galvan S, Tosti A, Shapiro J, Mesinkovska NA, Ramos PM, Sinclair R, Lupi O, Hercogova J, McCoy J. "Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine booster." Medical hypotheses, vol. 146, 2021, pp. 110439. |
Justo AS, Lemes BM, Nunes B, Antunes KA, Capote ACMO, Lipinski LC, Campagnoli EB, Emiliano J, Meurer EC, Ezemma O, Miot HA, Beltrame FL, Wambier CG. "Characterization of the Activity of Croton tiglium Oil in Hetter's Very Heavy Phenol-Croton Oil Chemical Peels." Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2021. |
Chesnut WM, MacDonald S, Wambier CG. "Could diet and exercise reduce risk of COVID-19 syndemic?." Medical hypotheses, vol. 148, 2021, pp. 110502. |
Cadegiani FA, Goren A, Wambier CG, McCoy J. "Early COVID-19 therapy with azithromycin plus nitazoxanide, ivermectin or hydroxychloroquine in outpatient settings significantly improved COVID-19 outcomes compared to known outcomes in untreated patients." New microbes and new infections, vol. 43, 2021, pp. 100915. |
Peterson D, Wambier C, Dai F, Lampert R, Ahmad T, Yale KL, Mesinkovska NA, King B. "Electrocardiogram Findings in Patients with Alopecia Areata." Dermatology and Therapy, 2021. |
Wambier CG. "Focus on clinical outcomes of "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial"." International journal of antimicrobial agents, vol. 57, no. 1, 2021, pp. 106175. |
George EA, Castelo-Soccio L, Putterman E, Kuhn H, Wambier C, Qureshi A, Cho E. "Influence of climate factors on pediatric alopecia areata flares in Philadelphia, Pennsylvania." Scientific Reports, vol. 11, no. 1, 2021, pp. 21034. |
MacDonald S, Wambier CG. "Letter to the Editor on "COVID-19 Infection in Men on Testosterone Replacement Therapy"." The journal of sexual medicine, vol. 18, no. 6, 2021, pp. 1141-1142. |
Ghanian S, Wambier CG. "Letter to the Editor re: Baldassarri et al., 2021 "Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males"." EBioMedicine, vol. 68, 2021, pp. 103425. |
Tajalli M, Wambier CG. "Lucio's Phenomenon." New England Journal of Medicine, vol. 384, no. 17, 2021, pp. 1646. |
Gao Y, Li Y, Tan Y, Liu W, Ouaddi S, McCoy J, Kovacevic M, Situm M, Stanimirovic A, Li M, Wambier C, Goren A, Zou Y. "Novel cannabidiol aspartame combination treatment (JW-100) significantly reduces ISGA score in atopic dermatitis: Results from a randomized double-blinded placebo-controlled interventional study." Journal of Cosmetic Dermatology, 2021. |
Cadegiani F, Lin EM, Goren A, Wambier CG. "Potential risk for developing severe COVID-19 disease among anabolic steroid users." BMJ Case Reports, vol. 14, no. 2, 2021. |
McCoy J, Goren A, Cadegiani FA, Vaño-Galván S, Kovacevic M, Situm M, Shapiro J, Sinclair R, Tosti A, Stanimirovic A, Fonseca D, Dorner E, Onety DC, Zimerman RA, Wambier CG. "Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial." Frontiers in Medicine, vol. 8, 2021, pp. 668698. |
Wambier CG, Tosti A. "Reply to early onset effluvium secondary to COVID-19 and body-hair effluvium." Journal of the American Academy of Dermatology, 2021. |
Ghanian S, Wambier CG. "Response to "Microneedling with autologous platelet-rich plasma versus microneedling with topical insulin in the treatment of postacne atrophic scars: A simultaneous split-face comparative study"." Journal of the American Academy of Dermatology, 2021. |
Cavanagh G, Goren A, Wambier CG. "Scalp Neuropathy in Androgenetic Alopecia." Journal of the American Academy of Dermatology, 2021. |
Dhurat R, Shukla D, Lim RK, Wambier CG, Goren A. "Spironolactone in adolescent acne vulgaris." Dermatologic Therapy, vol. 34, no. 1, 2021, pp. e14680. |
Abrantes TF, Artounian KA, Falsey R, Simão JCL, Vañó-Galván S, Ferreira SB, Davis TL, Ridenour W, Goren A, Tosti A, Wambier CG. "Time of onset and duration of post-COVID-19 acute telogen effluvium." Journal of the American Academy of Dermatology, vol. 85, no. 4, 2021, pp. 975-976. |
Baldissera RL, Yang EJ, Schmitt JV, Lin E, Emanuel de Jesus F, Simões E Silva Enokihara MM, Wambier CG, Bagatin E. "Trichloroacetic acid peels for the treatment of acanthosis nigricans." Journal of the American Academy of Dermatology, 2021. |
Goren A, Vano-Galvan S, Wambier CG, McCoy J, Gomez-Zubiaur A, Moreno-Arrones OM, Shapiro J, Sinclair R, Gold MH, Kovacevic M, Mesinkovska NA, Goldust M, Washeni K. "A preliminary observation: Male pattern hair loss among hospitalized COVID-19 patients in Spain - A potential clue to the role of androgens in COVID-19 severity." Journal of Cosmetic Dermatology, 2020. |
McCoy J, Wambier CG, Herrera S, Vaño-Galván S, Gioia F, Comeche B, Ron R, Serrano-Villar S, Iwasiow RM, Tayeb MA, Cadegiani FA, Mesinkovska NA, Shapiro J, Sinclair R, Goren A. "Androgen Receptor Genetic Variant Predicts COVID-19 Disease Severity: A Prospective Longitudinal Study of Hospitalized COVID-19 Male Patients." Journal of the European Academy of Dermatology and Venereology, 2020. |
Wambier CG, Goren A, Vaño-Galván S, Ramos PM, Ossimetha A, Nau G, Herrera S, McCoy J. "Androgen sensitivity gateway to COVID-19 disease severity." Drug development research, 2020. |
Wambier, Carlos Gustavo, Goren, Andy, Ossimetha, Angelina, Nau, Gerard, Qureshi, Abrar A, Carlos, Gustavo, None, None. "Androgen-driven COVID-19 pandemic theory." Unpublished, 2020. |
Wambier CG, Vaño-Galván S, McCoy J, Pai S, Dhurat R, Goren A. "Androgenetic alopecia in COVID-19: compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign." Journal of the American Academy of Dermatology, 2020. |
Wambier, Carlos Gustavo, Vaño-Galván, Sergio, McCoy, John, Gomez-Zubiaur, Alba, Herrera, Sabina, Hermosa-Gelbard, Ángela, Moreno-Arrones, Oscar M., Jiménez-Gómez, Natalia, González-Cantero, Alvaro, Pascual, Pablo Fonda, Segurado-Miravalles, Gonzalo, Shapiro, Jerry, Pérez-García, Bibiana, Goren, Andy. "Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients – the “Gabrin sign”." Journal of the American Academy of Dermatology, 2020. |
Goren A, Wambier CG, Herrera S, McCoy J, Vaño-Galván S, Gioia F, Comeche B, Ron R, Serrano-Villar S, Ramos PM, Cadegiani FA, Kovacevic M, Tosti A, Shapiro J, Sinclair R. "Anti-androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men." Journal of the European Academy of Dermatology and Venereology, 2020. |
Lim RK, Wambier CG, Goren A. "Are night shift workers at an increased risk for COVID-19?." Medical hypotheses, vol. 144, 2020, pp. 110147. |
Cadegiani FA, Lim RK, Goren A, McCoy J, Situm M, Kovacevic M, Vañó Galván S, Sinclair R, Tosti A, Wambier CG. "Clinical Symptoms of Hyperandrogenic Women Diagnosed with COVID-19." Journal of the European Academy of Dermatology and Venereology, 2020. |
Goren A, Wambier CG, McCoy J, Shapiro J, Vaño-Galván S, Herrera S, Glode LM. "Clock genes may drive seasonal variation in SARS-CoV-2 infectivity: are we due for a second wave of COVID-19 in the fall?." Journal of biological regulators and homeostatic agents, vol. 34, no. 4, 2020. |
Pompeu Raminelli AC, Rodrigues-Oliveira AF, Yokota R, Sumita JM, Oliveira-Silva D, Wambier CG, Bagatin E, Leonardi GR. "Cutaneous absorption of tretinoin in 0.05% cream and 5% chemical peel formulas." Journal of the American Academy of Dermatology, vol. 83, no. 5, 2020, pp. 1483-1485. |
da Silva Justo A, Lemes BM, Nunes B, Antunes KA, Carletto B, Koga AY, Lipinski LC, Montemor Netto MR, Blaum EC, Beltrame FL, Wambier CG. "Depth of injury of Hetter's phenol-croton oil chemical peel formula using two different emulsifying agents." Journal of the American Academy of Dermatology, 2020. |
Lemes BM, Andrade EA, Cruz LS, Minozzo BR, Carey WD, Damsky W, Miot HA, Beltrame FL, Wambier CG. "Effect of injection solutions in the dispersion of syringe lubricant (silicone oil)." Journal of the American Academy of Dermatology, vol. 82, no. 3, 2020, pp. 747-749. |
Wambier, Carlos Gustavo. "Focus on clinical outcomes of "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial." Zenodo, 2020. |
Lin EM, Goren A, Wambier C. "Letter to the Editor: Environmental Effects on Reported Infections and Death Rates of COVID-19 Across 91 Major Brazilian Cities." High altitude medicine & biology, 2020. |
Wambier CG, McCoy J, Goren A. "Male balding as a major risk factor for severe COVID-19: a possible role for targeting androgens and transmembrane protease serine 2 to protect vulnerable individuals." Journal of the American Academy of Dermatology, 2020. |
Sharma A, Surve R, Dhurat R, Sinclair R, Tan T, Zou Y, Müller Ramos P, Wambier C, Verner I, Kovacevic M, Goren A. "Microneedling improves minoxidil response in androgenetic alopecia patients by upregulating follicular sulfotransferase enzymes." Journal of biological regulators and homeostatic agents, vol. 34, no. 2, 2020, pp. 659-661. |
Ramos PM, Gohad P, McCoy J, Wambier C, Goren A. "Minoxidil Sulfotransferase Enzyme (SULT1A1) genetic variants predicts response to oral minoxidil treatment for female pattern hair loss." Journal of the European Academy of Dermatology and Venereology, 2020. |
Gohad P, McCoy J, Wambier C, Kovacevic M, Situm M, Stanimirovic A, Goren A. "Novel cannabidiol sunscreen protects keratinocytes and melanocytes against ultraviolet B radiation." Journal of Cosmetic Dermatology, 2020. |
Ramos PM, McCoy J, Wambier C, Shapiro J, Vañó-Galvan S, Sinclair R, Goren A. "Novel topical booster enhances follicular sulfotransferase activity in patients with androgenetic alopecia: a new strategy to improve minoxidil response." Journal of the European Academy of Dermatology and Venereology, 2020. |
Cavanagh G, Criado PR, Pagliari C, Oliveira Carneiro FR, Simões Quaresma JA, Cappel MA, Wambier C. "Pernio during the COVID-19 pandemic and review of inflammation patterns and mechanisms of hypercoagulability." JAAD Case Reports, vol. 6, no. 9, 2020, pp. 898-899. |
McCoy J, Wambier CG, Vano-Galvan S, Shapiro J, Sinclair R, Müller Ramos P, Washenik K, Andrade M, Herrera S, Goren A. "Racial Variations in COVID-19 Deaths May Be Due to Androgen Receptor Genetic Variants Associated with Prostate Cancer and Androgenetic Alopecia. Are Anti-Androgens a Potential Treatment for COVID-19?." Journal of Cosmetic Dermatology, 2020. |
Cavanagh, Gregory, Wambier, Carlos. "Rational hand hygiene during COVID-19 pandemic." Journal of the American Academy of Dermatology, 2020. |
Wambier CG. "Reply to "Comment on androgenetic alopecia present in the majority of patients hospitalized with COVID-19"." Journal of the American Academy of Dermatology, 2020. |
Wambier CG, Vaño-Galván S, Goren A. "Reply to comment on: The "Gabrin sign"." Journal of the American Academy of Dermatology, 2020. |
Cavanagh G, Wambier C. "Reply to: Personal Protective Equipment Recommendations Based on COVID-19 Route of Transmission." Journal of the American Academy of Dermatology, 2020. |
Lee KC, Wright M, Kulesza J, Brody HJ, Wambier C, International Peeling Society. "Reviving the call for weight by volume standardization of trichloroacetic acid peel solutions." Journal of the American Academy of Dermatology, 2020. |
Wambier CG, Goren A. "SARS-COV-2 infection is likely to be androgen mediated." Journal of the American Academy of Dermatology, 2020. |
Abrahams C, Melo GB, Wambier CG. "Silicone-rich syringes can cause granuloma-rich reactions in platelet-rich plasma injections." JAAD Case Reports, vol. 6, no. 8, 2020, pp. 751-752. |
Cadegiani FA, Goren A, Wambier CG. "Spironolactone may provide protection from SARS-CoV-2: Targeting androgens, angiotensin converting enzyme 2 (ACE2), and renin-angiotensin-aldosterone system (RAAS)." Medical hypotheses, vol. 143, 2020, pp. 110112. |
Cadegiani FA, Wambier CG, Goren A. "Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19." Frontiers in Medicine, vol. 7, 2020, pp. 453. |
Neitzke IC, de Grande Curi D, Lin EM, Lee KC, Soon SL, Lunardelli Bittencourt AC, Aguiar CM, Neto DJ, Cray da Costa Filha AR, Beltrame FL, Döll-Boscardin PM, Wambier CG. "Translational research on the role of formula stability in Hetter's Phenol-Croton oil peels: analysis of chemical studies and clinical outcomes from a randomized, double-blinded, split-face controlled trial." Journal of the American Academy of Dermatology, 2020. |
Goren A, Mc Coy J, Wambier CG, Vano-Galvan S, Shapiro J, Dhurat R, Washenik K, Lotti T. "WHAT DOES ANDROGENETIC ALOPECIA HAVE TO DO WITH COVID-19? AN INSIGHT INTO A POTENTIAL NEW THERAPY." Dermatologic Therapy, 2020, pp. e13365. |
Wambier CG, Lee KC, Soon SL, Sterling JB, Rullan PP, Landau M, Brody HJ, International Peeling Society. "Advanced chemical peels: Phenol-croton oil peel." Journal of the American Academy of Dermatology, vol. 81, no. 2, 2019, pp. 327-336. |
Wambier CG, Neitzke IC, Lee KC, Soon SL, Rullan PP, Landau M, Simão JCL, Sterling JB, Brody HJ, International Peeling Society. "Augmentation and eversion of lips without injections: The lip peel." Journal of the American Academy of Dermatology, vol. 80, no. 5, 2019, pp. e119-e120. |
Lee KC, Wambier CG, Soon SL, Sterling JB, Landau M, Rullan P, Brody HJ, International Peeling Society. "Basic chemical peeling: Superficial and medium-depth peels." Journal of the American Academy of Dermatology, vol. 81, no. 2, 2019, pp. 313-324. |
Wambier CG, Craiglow BG, King BA. "Combination tofacitinib and oral minoxidil treatment for severe alopecia areata." Journal of the American Academy of Dermatology, 2019. |
Wambier CG, Lee KC, Bertolini TM, Rullan PP, Beltrame FL. "Comment on "Anti-aging effects of ingenol mebutate for patients with actinic keratosis" and phenol-croton oil peelings." Journal of the American Academy of Dermatology, vol. 80, no. 6, 2019, pp. e185-e186. |
Wambier CG, Lee KC, Oliveira PB, Wambier SPF, Beltrame FL. "Comment on "Surgical smoke: Risk assessment and mitigation strategies" and chemical adsorption by activated carbon N95 masks." Journal of the American Academy of Dermatology, vol. 80, no. 4, 2019, pp. e79-e80. |
Sterling JB, Lee KC, Wambier CG, Soon SL, Landau M, Rullan PP, Brody HJ. "Depth Map for Face and Neck Deep Chemical Peel Resurfacing." Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2019. |
Wambier CG, Hoekstra TA, Wambier SPF, Bueno Filho R, Vilar FC, Paschoal RS, Roselino AM, Frade MAC, Foss NT. "Epidermal necrolysis: SCORTEN performance in AIDS and non-AIDS patients." Anais brasileiros de dermatologia, vol. 94, no. 1, 2019, pp. 17-23. |
Wambier CG, Assis de Andrade E, Cruz LS, Lemes BM, Carey WD, de Paula Silveira Moura B, Both AS, Perillo de Farias Wambier S, Beltrame FL. "Flush technique to minimize adverse reactions from syringe lubricant (silicone oil)." Journal of the American Academy of Dermatology, vol. 81, no. 6, 2019, pp. e169-e171. |
Ortolan LS, Kim SR, Crotts S, Liu LY, Craiglow BG, Wambier C, Paschoal RS, King BA, Jabbari A. "IL-12/IL-23 neutralization is ineffective for alopecia areata in mice and humans." Journal of Allergy and Clinical Immunology, vol. 144, no. 6, 2019, pp. 1731-1734.e1. |
Wambier CG, King BA. "Reply to: "Comment on 'Rule of thumb: A simple tool to estimate 1% scalp surface area': Whose thumb is it anyway?." Journal of the American Academy of Dermatology, vol. 81, no. 6, 2019, pp. e185. |
Wambier CG, Korgavkar K, Beltrame FL, Lee KC. "Response to "Clinical and Histologic Evaluation of Ingenol Mebutate 0.015% Gel for the Cosmetic Improvement of Photoaged Skin"." Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], vol. 45, no. 6, 2019, pp. 857-859. |
Wambier CG, King BA. "Rethinking the classification of alopecia areata." Journal of the American Academy of Dermatology, vol. 80, no. 2, 2019, pp. e45. |
Wambier CG, King BA. "Rule of thumb: A simple tool to estimate 1% scalp surface area." Journal of the American Academy of Dermatology, vol. 81, no. 2, 2019, pp. 630-631. |
Lee KC, Sterling JB, Wambier CG, Soon SL, Landau M, Rullan P, Brody HJ, International Peeling Society. "Segmental phenol-Croton oil chemical peels for treatment of periorbital or perioral rhytides." Journal of the American Academy of Dermatology, vol. 81, no. 6, 2019, pp. e165-e166. |
Wambier CG, Wambier SPF. "Sepsis assessment in SJS/TEN: an important point overlooked? - Reply." Anais brasileiros de dermatologia, vol. 94, no. 6, 2019, pp. 774. |
Wambier CG, Miot HA, Yarak S. "Silicone Oil-Systemic Safety Data Still Pending." Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2019. |
Wambier CG, Perillo de Farias Wambier S, Pereira Soares MT, Breunig J, Cappel MA, Landau M. "5-Fluorouracil tattooing for idiopathic guttate hypomelanosis." Journal of the American Academy of Dermatology, vol. 78, no. 4, 2018, pp. e81-e82. |
Wambier CG, Beltrame FL. "Air Safety and Personal Protective Equipment for Phenol-Croton Oil Peels." Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], vol. 44, no. 7, 2018, pp. 1035-1037. |
Wambier CG. "Comment on "Activation of melanocytes in idiopathic guttate hypomelanosis after 5-fluorouracil infusion using a tattoo machine: Preliminary analysis of a randomized, split-body, single blinded, placebo controlled clinical trial"." Journal of the American Academy of Dermatology, vol. 79, no. 4, 2018, pp. e79. |
Wambier CG, Wambier SPF, Hexsel D. "Injectable poly-L-lactic acid: Instant hydration in lukewarm water bath and use of a thin needle to filter particles." Journal of the American Academy of Dermatology, vol. 79, no. 1, 2018, pp. e3-e4. |
Wambier, Carlos Gustavo, Paschoal, Renato Soriani, Forno, Taciana Dal’, Lee, Kachiu Cecilia. "Pesquisa de opinião sobre eficácia, custos e cicatrização de procedimentos de resurfacing para rugas estáticas faciais." Surgical & Cosmetic Dermatology, vol. 10, no. 4, 2018. |
Wambier CG, Wambier SPF, Pilatti LEP, Grabicoski JA, Wambier LF, Schmidt A. "Prolongation of rate-corrected QT interval during phenol-croton oil peels." Journal of the American Academy of Dermatology, vol. 78, no. 4, 2018, pp. 810-812. |
Wambier CG, Danilau Ostroski TK, Perillo de Farias Wambier S, Beltrame FL, Cappel MA, Piñeiro Maceira JM. "Syringe lubricant and adverse reactions." International Journal of Dermatology, vol. 57, no. 1, 2018, pp. 122-123. |
de Nardo Vanzela T, Bernardes Filho F, Wambier CG, Faria FM, Foss NT, Frade MAC. "Th17 Response of Borderline-Lepromatous Leprosy Inhibits Rash Manifestation of Dapsone Hypersensitivity Syndrome: Case Report." The American Journal of Dermatopathology, vol. 40, no. 3, 2018, pp. 205-208. |
Wambier, Carlos Gustavo. "Beard alopecia caused by deoxycholic acid for the treatment of submental fat." Surgical & Cosmetic Dermatology, vol. 9, no. 3, 2017. |
Wambier, Carlos Gustavo, Brody, Harold J., Hetter, Gregory P. "Comments: Hemiface comparative study of two phenol peels (Baker-Gordon and Hetter formulas) for the correction of facial rhytids." Surgical & Cosmetic Dermatology, vol. 9, no. 2, 2017. |
Wambier CG, Cappel MA, Werner B, Rodrigues E, Schumacher Welling MS, Montemór Netto MR, de Farias Wambier SP. "Dermoscopic diagnosis of scurvy." Journal of the American Academy of Dermatology, vol. 76, no. 2S1, 2017, pp. S52-S54. |
Wambier CG, Cappel MA, Danilau Ostroski TK, Montemor Netto MR, de Farias Wambier SP, Santos de Jesus BL, Arruda E. "Familial outbreak of eruptive pseudoangiomatosis with dermoscopic and histopathologic correlation." Journal of the American Academy of Dermatology, vol. 76, no. 2S1, 2017, pp. S12-S15. |
Wambier CG, Struecker TA, Durski LN, de Araújo AG, Wambier SPF, Cappel MA, Vernal S, Roselino AM. "Image Gallery: A case of pemphigus vulgaris following Simulium spp. (Diptera) bites." Br J Dermatol, vol. 176, no. 5, 2017, pp. e100. |
Wambier CG, Cappel MA, Wambier SPF. "Treatment of reaction to red tattoo ink with intralesional triamcinolone." Anais brasileiros de dermatologia, vol. 92, no. 5, 2017, pp. 748-750. |
Wambier CG, Wambier SP, Furini RB, Simão JC, Frade MA, Foss NT. "Factors associated with seropositivity for APGL-Iamong household contacts of leprosy patients." Revista da Sociedade Brasileira de Medicina Tropical, vol. 49, no. 1, 2016, pp. 83-9. |
Wambier CG, Ramalho LN, Frade MA, Foss NT. "NFκB activation in cutaneous lesions of leprosy is associated with development of multibacillary infection." Journal of inflammation research, vol. 7, 2014, pp. 133-8. |
Wambier CG, Pereira CS, Prado Júnior Bde P, Foss NT. "Brazilian blood donation eligibility criteria for dermatologic patients." Anais brasileiros de dermatologia, vol. 87, no. 4, 2012, pp. 590-5. |
Zenha EM, Wambier CG, Novelino AL, de Andrade TA, Ferreira MA, Frade MA, Foss NT. "Clinical and immunological evaluation after BCG-id vaccine in leprosy patients in a 5-year follow-up study." Journal of inflammation research, vol. 5, 2012, pp. 125-35. |
Wambier CG, Wambier SP. "Gamasoidosis illustrated--from the nest to dermoscopy." Anais brasileiros de dermatologia, vol. 87, no. 6, 2012, pp. 926-7. |
Wambier CG, Lemos FB, Cappel MA, Bellissimo-Rodrigues F, Foss NT. "Generalized serpiginous eruption during immunosuppressive treatment for leprosy reactive neuritis." PLOS Neglected Tropical Diseases, vol. 5, no. 12, 2011, pp. e1357. |
Wambier CG, Foss-Freitas MC, Paschoal RS, Tomazini MV, Simão JC, Foss MC, Foss NT. "Severe hypoglycemia after initiation of anti-tumor necrosis factor therapy with etanercept in a patient with generalized pustular psoriasis and type 2 diabetes mellitus." Journal of the American Academy of Dermatology, vol. 60, no. 5, 2009, pp. 883-5. |
My expertise in both clinical and research realms of dermatology are in procedural dermatology, infectious diseases, and autoimmune/inflammatory diseases. Before joining Brown University, I was a faculty member of the University of Sao Paulo as attending, University of Ribeirao Preto as Assistant Professor, State University of Ponta Grossa as Associate Professor, and Yale School of Medicine as a Postdoctoral Associate. I have authored over 60 peer-reviewed publications. The main focus of my studies is to advance dermatology therapy and to improve the safety of current dermatologic interventions and safety.
Year | Degree | Institution |
---|---|---|
2012 | PhD | Universidade de São Paulo (USP) |
2004 | MD | University of Sao Paulo |
Postdoctorate | Yale University School of Medicine, Department of Dermatology | 2019-2020 | New Haven, CT, USA |
PhD in Dermatology | Ribeirão Preto School of Medicine - University of Sao Paulo, Hospital das Clínicas de Ribeirão Preto, Division of Dermatology | 2009-2012 | Ribeirão Preto, SP, Brazil |
2005 Highest overall ranking score. 2005 Residency Entrance Examinations, Medical Residency
Committee of Hospital of Clinics of Ribeirao Preto Medical School, University of Sao Paulo. Ribeirao Preto, SP, Brazil.
2005 Honorary Crew Member of "Carlos Chagas Ship for Hospital Care" Brazilian Navy.
2008 1st place award in: VIII annual Photography Contest of the Hospital of Clinics of Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, SP, Brazil.
2009 2nd place award in: 1st International Dermatology Photography Contest, DermQuest.com, Derm101. “Disseminated Bullous Cutaneous Larva Migrans”
2011 Dr. Diltor Vladimir Araujo Opromolla Award - for scientific investigation in Sanitary Dermatology (Endemic Infectious Diseases), Brazilian Society of Dermatology (SBD).
2011 1st place award in: Scientific Investigation in the XVI Annual Meeting of Dermatologists of Sao Paulo State (RADESP-SBD), 2011.
2016 1st place award in: 21st International Meeting of Dentistry – Brazilian Association of Dentistry (ABO). “Pemphigus Vulgaris in a young adult – case report”.
2019 Periocular Deep Chemical Peel before-after photography featured in the cover of the 40th anniversary issue of the Journal of the American Academy of Dermatology, issue of 2 CME Articles about Chemical Peels, Aug 2019.
2021 “Editor’s picks for the year 2020”, Journal of the European Academy of Dermatology and Venereology (2 articles mentioned), Jan 2021.
2021 Invited Lecture at the Brazilian National Academy of Medicine, “Androgen Vulnerability to COVID19: A new therapeutic frontier”.
2022 “Cureus Laurate” Title, in recognition of extraordinary contributions to the Cureus Journal of Medical Science, April 12, 2022.
Name | Title |
---|---|
Kuhn, Helena | Assistant Professor of Dermatology, Clinician Educator |
Nau, Gerard | Associate Professor of Medicine, Clinician Educator |
Qureshi, Abrar | Warren Alpert Foundation Professor of Dermatology, Professor of Epidemiology, Chair of Dermatology |
Brazilian Society of Dermatology (SBD). 2008-2019.
Brazilian Society for Dermatologic Surgery (SBCD). 2015-2019.
International Peeling Society (IPS). 2015-present
American Academy of Dermatology (AAD). 2016-present.
American Society for Dermatologic Surgery (ASDS). 2017-present.
Association of Professors of Dermatology (APD). 2018-present.
American Burn Association (ABD). 2022- present.
Medical License | Rhode Island Board of Medical Licensure & Discipline | 2020- | #MD17358 |
Physician/Surgeon | Connecticut Department of Public Health | 2018- | |
Board Certified in Dermatology | Brazilian Board of Dermatology, Dermatology | 2009- |